drugset / Trial / NCT03486080
Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction
Timeline
- Start
- 2018-12-07
- Primary completion
- 2021-02-26
- Completion
- 2021-02-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dutogliptin | Small molecule | 60 mg | Subcutaneous |
| Comparator | filgrastim | Protein / enzyme biologic | 10 ug/kg | Subcutaneous |